Report for McMahon LR

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Untapped endocannabinoid pharmacological targets: pipe dream or pipeline? - Wilkerson_2021_Pharmacol.Biochem.Behav__173192
Author(s) : Wilkerson JL , Bilbrey JA , Felix JS , Makriyannis A , McMahon LR
Ref : Pharmacol Biochem Behav , :173192 , 2021
Abstract : Wilkerson_2021_Pharmacol.Biochem.Behav__173192
ESTHER : Wilkerson_2021_Pharmacol.Biochem.Behav__173192
PubMedSearch : Wilkerson_2021_Pharmacol.Biochem.Behav__173192
PubMedID: 33932409

Title : Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery - Obeng_2021_J.Med.Chem_64_6523
Author(s) : Obeng S , Hiranita T , Leon F , McMahon LR , McCurdy CR
Ref : Journal of Medicinal Chemistry , 64 :6523 , 2021
Abstract : Obeng_2021_J.Med.Chem_64_6523
ESTHER : Obeng_2021_J.Med.Chem_64_6523
PubMedSearch : Obeng_2021_J.Med.Chem_64_6523
PubMedID: 33956427

Title : Hydrolysis and enzymatic degradation of Novichok nerve agents - Harvey_2020_Heliyon_6_e03153
Author(s) : Harvey SP , McMahon LR , Berg FJ
Ref : Heliyon , 6 :e03153 , 2020
Abstract : Harvey_2020_Heliyon_6_e03153
ESTHER : Harvey_2020_Heliyon_6_e03153
PubMedSearch : Harvey_2020_Heliyon_6_e03153
PubMedID: 32042950

Title : Nicotine-like discriminative stimulus effects of acetylcholinesterase inhibitors and a muscarinic receptor agonist in rhesus monkeys - Moerke_2019_Drug.Dev.Ind.Pharm__1
Author(s) : Moerke MJ , McMahon LR
Ref : Drug Dev Ind Pharm , :1 , 2019
Abstract : Moerke_2019_Drug.Dev.Ind.Pharm__1
ESTHER : Moerke_2019_Drug.Dev.Ind.Pharm__1
PubMedSearch : Moerke_2019_Drug.Dev.Ind.Pharm__1
PubMedID: 30712397

Title : An OPAA enzyme mutant with increased catalytic efficiency on the nerve agents sarin, soman, and GP - Bae_2018_Enzyme.Microb.Technol_112_65
Author(s) : Bae SY , Myslinski JM , McMahon LR , Height JJ , Bigley AN , Raushel FM , Harvey SP
Ref : Enzyme Microb Technol , 112 :65 , 2018
Abstract : Bae_2018_Enzyme.Microb.Technol_112_65
ESTHER : Bae_2018_Enzyme.Microb.Technol_112_65
PubMedSearch : Bae_2018_Enzyme.Microb.Technol_112_65
PubMedID: 29499783

Title : Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice - Ghosh_2015_J.Pharmacol.Exp.Ther_354_111
Author(s) : Ghosh S , Kinsey SG , Liu QS , Hruba L , McMahon LR , Grim TW , Merritt CR , Wise LE , Abdullah RA , Selley DE , Sim-Selley LJ , Cravatt BF , Lichtman AH
Ref : Journal of Pharmacology & Experimental Therapeutics , 354 :111 , 2015
Abstract : Ghosh_2015_J.Pharmacol.Exp.Ther_354_111
ESTHER : Ghosh_2015_J.Pharmacol.Exp.Ther_354_111
PubMedSearch : Ghosh_2015_J.Pharmacol.Exp.Ther_354_111
PubMedID: 25998048

Title : Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Delta9-tetrahydrocannabinol in mice - Hruba_2015_J.Pharmacol.Exp.Ther_353_261
Author(s) : Hruba L , Seillier A , Zaki A , Cravatt BF , Lichtman AH , Giuffrida A , McMahon LR
Ref : Journal of Pharmacology & Experimental Therapeutics , 353 :261 , 2015
Abstract : Hruba_2015_J.Pharmacol.Exp.Ther_353_261
ESTHER : Hruba_2015_J.Pharmacol.Exp.Ther_353_261
PubMedSearch : Hruba_2015_J.Pharmacol.Exp.Ther_353_261
PubMedID: 25711338